Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter Ablation

Clinical trial NCT02942576 · COMPLETED

Trial details

NCT number: NCT02942576
Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atrial Fibrillation

Start date: 2017-03-21
Primary completion: 2018-09-24
Enrollment: 632

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.